Icatibant
Overview
Carnitine is a betaine derivative found in skeletal muscle and liver. Carnitine is required for mitochondrial ß oxidation of fatty acids. Carnitine is involved in energy metabolism. It has been used as an investigational antithyroid and antiangina agent.
Primary Characterstics
It is of Synthetic origin and belongs to Decapeptide. It belongs to Bradykinin type II receptor Antagonist pharmacological group on the basis of mechanism of action.
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Icatibant's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 30 to 0 mg | 15 (15) | 24 hourly | SC | Icatibant is injected Slowly due to volume to be administered is 3ml.
if insufficiency , 2nd injection after 6hours, if needed, again after 6 hours, but not more than 3 in a period of 24hours. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Icatibant is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Icatibant is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Icatibant
Back to top
Previous Drug Generic - Next Drug Generic